Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 09/06/2024 at 16:00, 2 months 15 days ago

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
Jaguar Health, Inc. (NASDAQ:JAGX) founder Lisa Conte to present virtually at H.C. Wainwright Global Investment Conference. Focus on plant-derived medicines for gastrointestinal distress

Gastrointestinal Distress Jaguar Health Lisa Conte H.C. Wainwright Plant-derived Medicines
BRIEF

published on 09/05/2024 at 14:35, 2 months 16 days ago

Jaguar Health Celebrates National Service Dog Month Highlighting Its Cancer Care Drugs

Cancer Care FDA Approval Jaguar Health Canalevia-CA1 Service Dogs
BRIEF

published on 09/05/2024 at 14:35, 2 months 16 days ago

Jaguar Health célèbre le mois national des chiens d'assistance en mettant en avant ses médicaments contre le cancer

Canalevia-CA1 Soins Contre Le Cancer Approbation De La FDA Santé Jaguar Chiens D'assistance
PRESS RELEASE

published on 09/05/2024 at 14:30, 2 months 16 days ago

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Jaguar Health's Canalevia-CA1 drug receives FDA conditional approval for chemotherapy-induced diarrhea treatment in dogs, making it the first approved treatment for this condition

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Dogs
BRIEF

published on 09/04/2024 at 16:05, 2 months 17 days ago

Jaguar Health Announces Key Commercial and Development Milestones

Crofelemer Clinical Trials Jaguar Health Rare Diseases Gelclair®
BRIEF

published on 09/04/2024 at 16:05, 2 months 17 days ago

Jaguar Health annonce des étapes clés en matière de développement et de commercialisation

Crofelemer Essais Cliniques Maladies Rares Santé Jaguar Gelclair®
PRESS RELEASE

published on 09/04/2024 at 16:00, 2 months 17 days ago

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details

Jaguar Health Inc. Rare Diseases Gelclair Launch Crofelemer Trials Lisa Conte Interview
BRIEF

published on 08/27/2024 at 16:05, 2 months 25 days ago

Un brevet délivré en Jordanie renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement du syndrome de l'intestin court (SIC)

Crofelemer Propriété Intellectuelle Brevet Santé Jaguar Syndrome De L'intestin Court
BRIEF

published on 08/27/2024 at 16:05, 2 months 25 days ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

Crofelemer Short Bowel Syndrome Patent Jaguar Health Intellectual Property
PRESS RELEASE

published on 08/27/2024 at 16:00, 2 months 25 days ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Jaguar Health, Inc. announces issuance of new patent for crofelemer to treat rare diseases like SBS and MVID, enhancing IP protection. Independent studies supported in US, EU, and MENA regions

Crofelemer Patent Jaguar Health Rare Diseases SBS

Accesswire

Published on 11/22/2024 at 00:00, 6 hours 10 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 8 hours 5 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 20 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 55 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 10 hours ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 11 hours 8 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 33 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 12 hours 11 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 12 hours 18 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours 18 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 23 hours 12 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 23 hours 12 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 23 hours 12 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 10 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE